UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Management of ureteropelvic junction obstruction in children—a roundtable discussion

Journal of pediatric urology, 2019-08, Vol.15 (4), p.322-329

2019

Link zum Volltext

Verfügbarkeit prüfen

259 INTERIM ANALYSIS OF A PHASE I RADIOIMMUNOTHERAPY STUDY IN ADVANCED RENAL CELL CARCINOMA PATIENTS USING LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250

European urology supplements : official journal of the European Association of Urology, 2009-03, Vol.8 (4), p.185-185

2009

Link zum Volltext

Verfügbarkeit prüfen

563 SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.191-191

2010

Link zum Volltext

Verfügbarkeit prüfen

421 IMMUNOPET IMAGING OF RENAL CELL CARCINOMA WITH 1241-AND 89ZR-LABELED ANTI-CAIX MONOCLONAL ANTIBODY CG250

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.153-154

2010

Link zum Volltext

Verfügbarkeit prüfen

564 NEOADJUVANT SORAFENIB DECREASES T-REGULATORY CELLS INTRATUMORALLY IN RENAL CELL CARCINOMA (RCC) PATIENTS

European urology supplements : official journal of the European Association of Urology, 2010-04, Vol.9 (2), p.192-192

2010

Link zum Volltext

Verfügbarkeit prüfen

Renal Cell Carcinoma: Translational Biology, Personalized Medicine, and Novel Therapeutic Targets

1. Aufl., 2012

Link zum Volltext

Verfügbarkeit prüfen

862 RADIOIMMUNOTHERAPY OF ADVANCED RENAL CELL CARCINOMA PATIENTS WITH LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250

European urology supplements : official journal of the European Association of Urology, 2007, Vol.6 (2), p.238-238

2007

Link zum Volltext

Verfügbarkeit prüfen

THE VALUE OF THE PCA3 SCORE IN GUIDING PROSTATE BIOPSY DECISION IN MEN WITH A PRIOR NEGATIVE BIOPSY

European urology supplements : official journal of the European Association of Urology, 2008, Vol.7 (3), p.142-142

2008

Link zum Volltext

Verfügbarkeit prüfen

Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy

European urology, 2010-07, Vol.58 (1), p.75-83

2010

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer Gene 3 ( PCA3 ): Development and Internal Validation of a Novel Biopsy Nomogram

European urology, 2009-10, Vol.56 (4), p.659-668

2009

Link zum Volltext

Verfügbarkeit prüfen

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

European urology, 2008-11, Vol.54 (5), p.1081-1088

2008

Link zum Volltext

Verfügbarkeit prüfen

Two-Staged Sacral Neuromodulation for the Treatment of Nonobstructive Urinary Retention: A Multicenter Study Assessing Predictors of Success

Neuromodulation (Malden, Mass.), 2023-12, Vol.26 (8), p.1823-1830

2023

Link zum Volltext

Verfügbarkeit prüfen

Two-staged sacral neuromodulation procedure for the treatment of non-obstructive urinary retention: A multi-center study assessing predictors of success

European urology, 2022-02, Vol.81, p.S1259-S1260

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 Study of Lutetium 177–Labeled Anti–Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma

European urology, 2016-05, Vol.69 (5), p.767-770

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase 1 Radioimmunotherapy Study with Lutetium 177–labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma

European urology, 2013-09, Vol.64 (3), p.478-485

2013

Link zum Volltext

Verfügbarkeit prüfen

PO247 / #518 TWO-STAGED SACRAL NEUROMODULATION PROCEDURE FOR THE TREATMENT OF NON-OBSTRUCTIVE URINARY RETENTION: A MULTI-CENTER STUDY ASSESSING PREDICTORS OF SUCCESS

Neuromodulation (Malden, Mass.), 2022-10, Vol.25 (7), p.S349-S350

2022

Link zum Volltext

Verfügbarkeit prüfen

ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice

Cancer biotherapy & radiopharmaceuticals, 2013-09, Vol.28 (7), p.510

2013

Link zum Volltext

Verfügbarkeit prüfen

Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab

Journal of Nuclear Medicine, 2014-06, Vol.55 (6), p.1035-1040

2014

Link zum Volltext

Verfügbarkeit prüfen

The reverse side of the victory: Flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases

Acta oncologica, 2009, Vol.48 (6), p.927-931

2009

Link zum Volltext

Verfügbarkeit prüfen

Correspondence: Training opportunities in renal replacement access

Journal of pediatric urology, 2018-02, Vol.14 (1), p.87-88

2018

Link zum Volltext

Verfügbarkeit prüfen

Tyrosine Kinase Inhibitor Sorafenib Decreases 111 In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma

Journal of Nuclear Medicine, 2014-02, Vol.55 (2), p.242-247

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of Lutetium-177-labeled anti-Carbonic Anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e14014-e14014

2015

Link zum Volltext

Verfügbarkeit prüfen

111 In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib

Journal of Nuclear Medicine, 2010-11, Vol.51 (11), p.1707-1715

2010

Link zum Volltext

Verfügbarkeit prüfen

1216 DEVELOPMENT OF NOVEL PCA3 CUT-OFFS FOR INITIAL AND REPEAT BIOPSY USING DIFFERENT STATISTICAL APPROACHES WITHIN A US- EUROPEAN MULTI INSTITUTIONAL COHORT

The Journal of urology, 2012-04, Vol.187 (4), p.e492-e492

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(49)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Urology
(26)
Humans
(15)
Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Male
(12)
Middle Aged
(8)
Urology & Nephrology
(8)
Aged
(7)
Carcinoma, Renal Cell - Diagnostic Imaging
(6)
Female
(6)
Kidney Neoplasms - Diagnostic Imaging
(6)
Medical Sciences
(6)
Antibodies, Monoclonal - Therapeutic Use
(5)
Biological And Medical Sciences
(5)
Nephrology. Urinary Tract Diseases
(5)
Radionuclide Imaging
(5)
Tumors Of The Urinary System
(5)
Adult
(4)
Tumors
(4)
Antibodies, Monoclonal - Adverse Effects
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of ureteropelvic junction obstruction in children—a roundtable discussion

259 INTERIM ANALYSIS OF A PHASE I RADIOIMMUNOTHERAPY STUDY IN ADVANCED RENAL CELL CARCINOMA PATIENTS USING LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250

563 SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA

421 IMMUNOPET IMAGING OF RENAL CELL CARCINOMA WITH 1241-AND 89ZR-LABELED ANTI-CAIX MONOCLONAL ANTIBODY CG250

564 NEOADJUVANT SORAFENIB DECREASES T-REGULATORY CELLS INTRATUMORALLY IN RENAL CELL CARCINOMA (RCC) PATIENTS

Renal Cell Carcinoma: Translational Biology, Personalized Medicine, and Novel Therapeutic Targets

862 RADIOIMMUNOTHERAPY OF ADVANCED RENAL CELL CARCINOMA PATIENTS WITH LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250

THE VALUE OF THE PCA3 SCORE IN GUIDING PROSTATE BIOPSY DECISION IN MEN WITH A PRIOR NEGATIVE BIOPSY

Carbonic Anhydrase IX in Renal Cell Carcinoma: Implications for Prognosis, Diagnosis, and Therapy

Prostate Cancer Gene 3 ( PCA3 ): Development and Internal Validation of a Novel Biopsy Nomogram

Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy

Two-Staged Sacral Neuromodulation for the Treatment of Nonobstructive Urinary Retention: A Multicenter Study Assessing Predictors of Success

Two-staged sacral neuromodulation procedure for the treatment of non-obstructive urinary retention: A multi-center study assessing predictors of success

Phase 2 Study of Lutetium 177–Labeled Anti–Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma

Phase 1 Radioimmunotherapy Study with Lutetium 177–labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma

PO247 / #518 TWO-STAGED SACRAL NEUROMODULATION PROCEDURE FOR THE TREATMENT OF NON-OBSTRUCTIVE URINARY RETENTION: A MULTI-CENTER STUDY ASSESSING PREDICTORS OF SUCCESS

ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice

Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab

The reverse side of the victory: Flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases

The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free‐to‐total prostate‐specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?

Correspondence: Training opportunities in renal replacement access

Tyrosine Kinase Inhibitor Sorafenib Decreases 111 In-Girentuximab Uptake in Patients with Clear Cell Renal Cell Carcinoma

Phase II study of Lutetium-177-labeled anti-Carbonic Anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma

111 In-Bevacizumab Imaging of Renal Cell Cancer and Evaluation of Neoadjuvant Treatment with the Vascular Endothelial Growth Factor Receptor Inhibitor Sorafenib

1216 DEVELOPMENT OF NOVEL PCA3 CUT-OFFS FOR INITIAL AND REPEAT BIOPSY USING DIFFERENT STATISTICAL APPROACHES WITHIN A US- EUROPEAN MULTI INSTITUTIONAL COHORT

Suchergebnisse filtern